Unovis Alternative Protein Fund Grant
In context
This call is open to startups, small and medium-sized businesses and large companies, at seed stage, Series A and Series B and growth stage. Funding is an equity investment. Coverage is read from the notice itself: any country.
Unovis invests in entrepreneurs building alternative protein companies across plant-based, cellular agriculture, fermentation, and novel protein technologies. The fund supports companies from seed stage through scale, across the full production value chain.
About this grant
Unovis Asset Management operates an alternative protein venture fund that finds, funds, and fosters innovative companies working to sustainably feed the planet. The fund invests in purpose-driven entrepreneurs across the alternative protein production value chain, from disruptive start-ups to global conglomerates. Investment areas include protein R&D (crops, seeds, microbes, yeast, fungi, algae, biomatter, recombinant proteins, cultured proteins, tailored fats, allergen-free functional ingredients), product development, protein manufacturing (biomass fermentation, precision fermentation, protein isolation and formulation), food manufacturing (extrusion, food processing, dehydration, spinning fibers, 3D printing), and consumer goods, foodservice, and distribution channels. The fund provides support from seed stage onward and focuses on building lasting, collaborative global partnerships with innovators who share the vision of a well-fed and sustainable world. Impact, including UN Sustainable Development Goals, diversity/equity/inclusion, ESG mandates, and animal welfare, is described as a core driver of the fund's focus and activities.
Get the official link (free account)
Create a free account to open the official notice and application link: 1 official link a month, free. Pro opens every link.
Eligibility
Applicants must be companies or entrepreneurs working in the alternative protein or sustainable food space, particularly along the protein production value chain. The fund considers investments from seed stage onward and supports both disruptive start-ups and global conglomerates. There is no explicit geographic restriction stated; portfolio companies are based in the United States, Spain, Israel, and the Netherlands, suggesting global eligibility. The fund focuses specifically on plant-based, cellular agriculture, novel proteins, and convenience food sectors.
How it's scored
No explicit evaluation criteria, scoring rubrics, or panel composition details are provided on the page. The fund's stated priorities include alignment with its vision for a well-fed and sustainable world, impact orientation (UN SDGs, ESG mandates, DEI, animal welfare), innovation along the alternative protein value chain, and the disruptive or solutionary nature of the business idea.
Key requirements
- ✓Purpose-driven entrepreneurs building alternative protein value chain
- ✓Focus on plant-based, cellular agriculture, fermentation, or novel proteins
- ✓Seed stage and beyond (disruptive start-ups to global conglomerates eligible)
Recent past awardees
Knowing who's won the last rounds tells you whether you're in the strike zone.
- NOVAMEAT
- Nobell
- Oshi
- BlueNalu
- The Protein Brewery
- Black Sheep Foods
Frequently asked questions
- Who can apply for Unovis Alternative Protein Fund?
- Eligibility covers organisations in GLOBAL; startup, sme, large-company. See the eligibility criteria above for the full conditions.
Relevant sectors
About this sector
Alternative protein funding backs plant-based, fermentation-derived and cultivated proteins, along with the ingredients and processing they depend on. Support includes research grants, scale-up programmes and investment from specialist funds. Calls usually look for regulatory awareness, a route to lower production cost and partnerships with food manufacturers.
Free accounts: 1 official link a month · Pro: every link
Quick facts
Get alerts for notices like this
Create a free account and we save a search for this sector and country, so new grants like this one arrive in your weekly email.
Get alerts, free →